Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thyroid Cancer, Papillary 1Sarcoma 1Pancreatic carcinoma, familial 1Pancreatic Intraductal Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Medullary 1Cancer of Lymph Node 1Brain Neoplasms 1Adult Brain Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 16Blood Specimen Collection 8Temozolomide 5Magnetic Resonance Imaging 5Bevacizumab 4Yoga 3Radiotherapy, Intensity-Modulated 3Biopsy 3Transcranial Magnetic Stimulation 2Surveys and Questionnaires 2Restraint, Physical 2Radiosurgery 2Radiation 2Psychosocial Intervention 2Proton Therapy 2Physical Therapy Modalities 2Palliative Care 2Mind-Body Therapies 2Mental Status and Dementia Tests 2Heart Rate 2Gadolinium DTPA 2Exercise 2Elasticity Imaging Techniques 2Drug Therapy 2Diffusion Tensor Imaging 2Congresses as Topic 2Aminolevulinic Acid 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vandetanib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Glioma × Ferrosoferric Oxide × Clear all
NCT00103038 2022-06-09

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

OHSU Knight Cancer Institute

Phase NA Completed
155 enrolled 11 charts
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡